Literature DB >> 15538226

Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.

Michael Mullerad1, Paul Russo, Dragan Golijanin, Hui Ni Chen, Harold H Tsai, S Machele Donat, Bernard H Bochner, Harry W Herr, Joel Sheinfeld, Pramod C Sogani, Michael W Kattan, Guido Dalbagni.   

Abstract

PURPOSE: Upper tract transitional cell carcinoma (UTTCC) is a relatively rare tumor. Overall 5-year disease specific survival is in the range of 16.5% to 95% depending on stage. In this study we evaluated predictors associated with disease recurrence and disease specific survival.
MATERIALS AND METHODS: We report on 129 patients with a median age of 68 years who underwent nephroureterectomy for UTTCC between July 1989 and June 2002. A total of 67 patients had primary UTTCC and 62 had previous (52) or synchronous (10) transitional cell carcinoma of the bladder (BTCC). Medical records were reviewed and analyzed for possible prognostic predictors (primary tumor stage, grade, multifocality, carcinoma in situ, symptoms and signs at presentation, sex, and history of smoking). Disease specific survival and freedom from bladder recurrence were assessed with the Kaplan-Meier method, and differences between the groups were compared using the log rank test. The Cox proportional hazards regression model was used to assess the significance of each predictor.
RESULTS: Disease specific death was reported for 44 patients. In a multivariate analysis using previous BTCC as a predictor (categorized as superficial, invasive or none), primary disease stage and history of BTCC were associated with disease specific survival (p = 0.001 and p = 0.018). History of BTCC grouped the patients into distinct populations in terms of disease specific survival and freedom from bladder recurrence.
CONCLUSIONS: This study demonstrates that a history of BTCC (invasive or superficial) has an adverse effect on the prognosis of patients diagnosed with UTTCC independent of primary tumor stage.

Entities:  

Mesh:

Year:  2004        PMID: 15538226     DOI: 10.1097/01.ju.0000144505.40915.98

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  [Urothelial carcinoma of the upper urinary tract: clinical and pathological criteria and their predictive implications after radical nephroureterectomy].

Authors:  Christian Seitz; Paul Schramek
Journal:  Wien Med Wochenschr       Date:  2011-08

Review 2.  [Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors].

Authors:  M Rink; M Adam; J Hansen; F K Chun; S A Ahyai; M Remzi; T Schlomm; O Engel; R Heuer; C Eichelberg; M Fisch; R Dahlem; S F Shariat
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

Review 3.  Prognostic factors for upper urinary tract urothelial carcinoma.

Authors:  Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

4.  Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.

Authors:  Evanguelos Xylinas; Pierre Colin; François Audenet; Véronique Phe; Luc Cormier; Olivier Cussenot; Alain Houlgatte; Gilles Karsenty; Franck Bruyère; Thomas Polguer; Alain Ruffion; Antoine Valeri; François Rozet; Jean-Alexandre Long; Marc Zerbib; Morgan Rouprêt
Journal:  World J Urol       Date:  2012-09-30       Impact factor: 4.226

5.  Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study.

Authors:  Philipp Nuhn; Giacomo Novara; Christian Seitz; Amit Gupta; Kazumasa Matsumoto; Wassim Kassouf; Thomas J Walton; Hans-Martin Fritsche; Stefan Tritschler; Juan I Martínez-Salamanca; Vincenzo Ficarra; Pierre I Karakiewicz; Guido Mazzoleni; Shahrokh F Shariat; Patrick J Bastian
Journal:  World J Urol       Date:  2014-07-22       Impact factor: 4.226

6.  Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Authors:  Yasuyuki Kobayashi; Takashi Saika; Yoshiyuki Miyaji; Michinao Saegusa; Ryoji Arata; Naoki Akebi; Tadasu Takenaka; Daisuke Manabe; Yasutomo Nasu; Hiromi Kumon
Journal:  World J Urol       Date:  2011-07-30       Impact factor: 4.226

7.  Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma.

Authors:  Marco Cosentino; Joan Palou; Josep M Gaya; Alberto Breda; Oscar Rodriguez-Faba; Humberto Villavicencio-Mavrich
Journal:  World J Urol       Date:  2012-05-03       Impact factor: 4.226

8.  Prognostic significance of tumor location and superficial urothelial bladder carcinoma history in patients with ureteral urothelial carcinoma treated with radical nephroureterectomy.

Authors:  Jian-Ye Liu; Qun Zhang; Yun-Lin Ye; Jing Li; Wei Chen; Yong-Hong Li; Zhi-Ling Zhang; Kai Yao; Li-Juan Jiang; Hui Han; Zhou-Wei Liu; Zi-Ke Qin; Fang-Jian Zhou
Journal:  Int Urol Nephrol       Date:  2013-02-14       Impact factor: 2.370

9.  Simultaneous Cystectomy and Nephroureterectomy due to Synchronous Upper Urinary Tract Tumors and Invasive Bladder Cancer: Open and Laparoscopic Approaches.

Authors:  Manuel Pérez-Utrilla Pérez; Alfredo Aguilera Bazán; José M Alonso Dorrego; Rebeca Vitón Herrero; Jesús Cisneros Ledo; Javier de la Peña Barthel
Journal:  Curr Urol       Date:  2012-09-27

10.  Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

Authors:  C Langner; G Hutterer; T Chromecki; P Rehak; R Zigeuner
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.